Acharya Harihar Postgraduate Institute Of Cancer Gets Approval For 2 MCh Courses
- byDoctor News Daily Team
- 17 July, 2025
- 0 Comments
- 0 Mins
Odisha: Acharya Harihar Postgraduate Institute of Cancer, Cuttack has finally secured the recognition of the apex medical regulator for running M.Ch courses in the two departments of Surgical Oncology and Gynecological Oncology. The approval was given by the erstwhile Medical Council of India (MCI) which has now been taken over by the National Medical Commission (NMC)
The information of the approval comes via a recent letter received by the authorities at the medical college dated 17th September 2020 wherein the erstwhile board of governors, in supersession of Medical Council of India, accorded recognition to M.Ch in Surgical Oncology and M.Ch in Gynecological Oncology courses of Acharya Harihar Post Graduate Institute Of Cancer, Cuttack from this session.
The decision was taken after considering the standard of examination and teaching facilities available in the institution.
These courses were permitted by MCI in 2017. The first batch of students successfully completed the curriculum & passed the qualifying examinations in 2020.
Also Read:Goa Medical College seeks approval for 10 super speciality courses
In a letter forwarded to the Dean of the institution on 27th October from the board of governors in supersession of Medical Council of India, it was stated that " the board of governors considered the Council Assessor's Report together with the recommendation of PG expert group (BoG) and decided to recommend to the central government that M.Ch. (gynecological oncology) qualification for two seats being granted by Utkal University, Orissa in respect of students being trained at Acharya Harihar Regional Cancer Center Cuttack be recognized and included in the first schedule of the I.M.C act 1956."
The board of governors further decided that the " recognition so granted shall be for a maximum period of 5 years from the date of notification upon which the institute shall have to apply for renewal of recognition. Failure to seek timely renewal of the recognition as required shall invariably result in the stoppage of admission of the postgraduate courses." In a separate letter, the authorities have similarly granted permission for two seats of M.Ch. in Surgical Oncology as well under the same norms and conditions.
Board of Governors, in supersession of Medical Council of India, accorded recognition to https://t.co/udEfTWEALN. in Surgical Oncology and https://t.co/udEfTWEALN. in Gynecological Oncology courses of Acharya Harihar Post Graduate Institute Of Cancer, Cuttack from 2020. pic.twitter.com/wcTiun2N1P
— H & FW Dept Odisha (@HFWOdisha) October 28, 2020
On 24th April 1984, the Regional Cancer Centre was declared as an autonomous institution and was named Acharya Harihar Regional Cancer Centre, Cuttack, after the great dedicated social worker Acharya Harihara. Now, this hospital forms an important component for the treatment of cancer in the eastern part of India covering the whole state of Orissa and its neighboring states like Andhrapradesh, Chhatisgarh, West Bengal, Bihar and Jharkhand. It has well-developed departments including anesthesiology, gynecologic oncology, head and neck oncology, medical oncology, medical physics, pain and palliative care, pathology, radiodiagnosis, radiation oncology, surgical oncology, and dentistry.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Aadhaar authentication voluntary for NBE exams, cl...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!